RareGeniX Consulting
- Biotech or pharma, therapeutic R&D
- Institute, hospital research
- Investor (buy-side or sell-side research)
- Medical device or technology
- Other R&D services
- Patient advocacy
We’re a UK R&D consultancy with a few ‘unusuals’ you’ll want on your side:
- Unusually experienced—over 140 years of industry know-how packed into just 5 team members.
- Unusually small—and proud of it. You get direct access to top talent, no layers, no delays.
- Unusual services—think EU QP for EU imports, patient engagement/retention (vital in rare disease), plus clinical and CMC regulatory support, and end-to-end drug development.
- Unusually knowledgeable—from small molecules to ATMPs like CAR-T, mRNA, antisense oligos, ADCs, and viruses.
We help translate your innovation into an IMP to unlock funding, secure IND/CTA approval for more investment, and craft robust development plans to boost your development prospects.
Struggling with hard-to-recruit studies? We’ll help you get the data you need—if it’s positive, that’s more funding potential and a significant step closer to the market.
Let’s meet at BIO—one of our partners will happily share more and answer your burning R&D questions!